Clinical trial

Aspirin for Prevention of Preeclampsia

NCT03726177

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-12-01

PhaseNA

Study timeline

Study start (actual)2018-12-01Date precision: day

Registry last updated2019-01-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Preeclampsiaunresolved

Interventions

aspirin 162 mgDRUG · verified · RxNorm: aspirin 162 MG

aspirin 81 mgDRUG · verified · RxNorm: aspirin 81 MG

placeboDRUG

Sponsors & collaborators

Aswan University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03726177 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.